Tertiary Prevention in Type II Diabetes Mellitus in Canary Islands Study (INDICA)

September 27, 2021 updated by: Servicio Canario de Salud

Effectiveness and Cost-effectiveness of Two Multi-component Interventions to Improve the Health Outcomes in People With Type 2 Diabetes Mellitus

Objective:

  • To improve health outcomes of patients with type 2 diabetes mellitus (T2DM) by influencing disease self-management through lifestyle modification and by helping primary care professionals to improve health care provided to patients.
  • To assess the effectiveness and cost-effectiveness of two complex interventions (education and behavioural modification, independently and conjointly, for primary health care teams (PHCT) and patients and their relatives) to improve the health results in people with T2DM.

Methodology:

Design: Randomized clinical trial. Setting: Basic healthcare district in Canary Islands. Spain. Subjects: Patients with T2DM, 18-65 years old, without complications. Main measures: HbA1c, rate of patients with properly controlled T2DM. Sample: 2328 patients, 582 per arm. Intervention: G1: Interventions on the patients: Educational and habit modification group program. G2: Intervention on the PHCT: a) Educative intervention to improve the knowledge about the disease and their abilities; b) Computer-based clinical decision support system; c) Feedback of results. G3: Interventions on the patients and the PHCT. G4: Control group. Patients receive only the usual care.

Study Overview

Study Type

Interventional

Enrollment (Actual)

2334

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Santa Cruz de Tenerife, Spain, 38004
        • Servicio de Evaluación del Servicio Canario de la Salud

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

Patients:

  • T2DM diagnosis
  • aged between 18 and 65

Health professionals:

  • primary health care teams (PHCT) comprising a primary care physician and a nurse practitioner associated to a patient will be selected
  • must have a permanent position or a stable substitute position

Exclusion Criteria:

  • peripheral vascular disease
  • diabetic nephropathy and/or chronic kidney disease
  • cognitive impairment, dementia
  • major depression
  • insufficient level of Spanish
  • to be pregnant or planning to become pregnant in the next 6 months
  • cancer last 5 years
  • ischemic disease or heart failure
  • proliferative diabetic retinopathy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention to Patients
Only patients receive intervention

Multifaceted intervention consisting of:

  • Program of education and behavior modification: group sessions conducted by health educators for the patient and a relative (who usually do the food shopping or prepare meals) every 3 months over 2 years (total:8 sessions). Main contents: diabetes, hygiene/nutrition and physical exercise.
  • Monitoring of patient conditions by Informational Communication Technologies (ICT): patient will complete at home a web-based short questionnaire once a week and an expanded version once a month.
  • Short text messaging to patient's mobile based on information obtained from self-reported questionnaires. 3 types of messages: 1) Reminders for completing web-based questionnaires, the attendance at group sessions and the follow-up appointments, 2) General advice on good habits, 3) Custom messages to reinforce behavior change.
Usual care for T2DM received in primary health care
Experimental: Intervention to healthcare Professionals
Primary care physicians and nurses practitioners receive the intervention. Their associated patients do not receive direct intervention although indirect intervention through professionals
Usual care for T2DM received in primary health care

Multifaceted intervention consisting of:

  • Educational intervention: Two theoretical and practical sessions to update knowledge on T2DM management and provide professionals with techniques to enhance the patient-centered clinical relationship model and the shared decision making model with the ultimate goal of improving patient adherence to treatment and self-care.
  • Computer-based clinical decision support system (CDSS): Implementation of an automated tool combining evidence-based knowledge with patient-specific information to assist clinicians in making clinical decisions in the management of T2DM patients.
  • Feedback: periodic mailing of personalized feedback reports with data on health results of all T2DM patients who are cared by the professional.
Experimental: Mixed Intervention
Patients and healthcare professionals (primary care physicians and nurses practitioners) associated with these patients receive intervention

Multifaceted intervention consisting of:

  • Program of education and behavior modification: group sessions conducted by health educators for the patient and a relative (who usually do the food shopping or prepare meals) every 3 months over 2 years (total:8 sessions). Main contents: diabetes, hygiene/nutrition and physical exercise.
  • Monitoring of patient conditions by Informational Communication Technologies (ICT): patient will complete at home a web-based short questionnaire once a week and an expanded version once a month.
  • Short text messaging to patient's mobile based on information obtained from self-reported questionnaires. 3 types of messages: 1) Reminders for completing web-based questionnaires, the attendance at group sessions and the follow-up appointments, 2) General advice on good habits, 3) Custom messages to reinforce behavior change.
Usual care for T2DM received in primary health care

Multifaceted intervention consisting of:

  • Educational intervention: Two theoretical and practical sessions to update knowledge on T2DM management and provide professionals with techniques to enhance the patient-centered clinical relationship model and the shared decision making model with the ultimate goal of improving patient adherence to treatment and self-care.
  • Computer-based clinical decision support system (CDSS): Implementation of an automated tool combining evidence-based knowledge with patient-specific information to assist clinicians in making clinical decisions in the management of T2DM patients.
  • Feedback: periodic mailing of personalized feedback reports with data on health results of all T2DM patients who are cared by the professional.
Other: Control
Patients receive usual care
Usual care for T2DM received in primary health care

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Glycosylated hemoglobin (HbA1c)
Time Frame: Baseline and 12 months
Change in Glycosylated hemoglobin from baseline to 12 months
Baseline and 12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Glycosylated hemoglobin (HbA1c)
Time Frame: Baseline and 3, 6, 18 and 24 months
Baseline and 3, 6, 18 and 24 months
Change in Weight
Time Frame: Baseline and 3, 6, 12, 18 and 24 months
Baseline and 3, 6, 12, 18 and 24 months
Change in Waist circumference
Time Frame: Baseline and 3, 6, 12, 18 and 24 months
Baseline and 3, 6, 12, 18 and 24 months
Change in Body Mass Index (BMI)
Time Frame: Baseline and 3, 6,12, 18 and 24m
Baseline and 3, 6,12, 18 and 24m
Change in Basal glucose
Time Frame: Baseline and 3, 6, 12, 18 and 24 months
Baseline and 3, 6, 12, 18 and 24 months
Change in Total cholesterol level
Time Frame: Baseline and 6, 12 and 24 months
Baseline and 6, 12 and 24 months
Change in HDL level
Time Frame: Baseline and 6, 12 and 24 months
Baseline and 6, 12 and 24 months
Change in LDL level
Time Frame: Baseline and 6, 12 and 24 months
Baseline and 6, 12 and 24 months
Change in Triglycerides
Time Frame: Baseline and 6, 12 and 24 months
Baseline and 6, 12 and 24 months
Change in EQ-5D index
Time Frame: Baseline and 6, 12, 18 and 24 months
EQ-5D is a generic questionnaire for health related quality of life (HRQL) assessment
Baseline and 6, 12, 18 and 24 months
Change in ADDQoL score
Time Frame: Baseline and 6, 12, 18 and 24 months
ADDQoL is a specific questionnaire for health related quality of life (HRQL) assessment
Baseline and 6, 12, 18 and 24 months
Medication administration
Time Frame: Baseline and 6, 12, 18 and 24 months
Initiation of new drugs or dosage adjustment: insulin, antidiabetics, hypolipidemics, antihypertensives, etc.
Baseline and 6, 12, 18 and 24 months
Change in tabacco consumption
Time Frame: Baseline and 3, 6, 12, 18 and 24 months
Baseline and 3, 6, 12, 18 and 24 months
Acceptability of interventions and satisfaction (INDICA-SATP)
Time Frame: 24 months
24 months
Change in Diabetes Knowledge
Time Frame: Baseline, 12 and 24 months
Baseline, 12 and 24 months
Change in Mediterranean Diet Adherence Screener (MEDAS) score
Time Frame: Baseline and 6, 12, 18 and 24 months
Baseline and 6, 12, 18 and 24 months
Change in International Physical Activity Questionnarie (IPAQ) score
Time Frame: Baseline and 6, 12, 18 and 24 months
Baseline and 6, 12, 18 and 24 months
Change in Stait-Trait Anxiety Inventory (STAI) score
Time Frame: Baseline, 12 and 24 months
Baseline, 12 and 24 months
Change in Beck Depression Inventory - II (BDI-II) score
Time Frame: Baseline, 12 and 24 months
Baseline, 12 and 24 months
Change in Diabetes Distress Scale (DDS2) score
Time Frame: Baseline, 12 and 24 months
Baseline, 12 and 24 months
Change in Diabetes Empowerment Scale - Short Form (DES-SF) score
Time Frame: Baseline, 12 and 24 months
Baseline, 12 and 24 months
Change in Morisky Compliance Scale
Time Frame: Baseline and 6, 12, 18 and 24 months
Baseline and 6, 12, 18 and 24 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of micro- and macrovascular complications
Time Frame: Baseline, 12 and 24 months
Coronary events, peripheral vascular complications, cerebral vascular complications, diabetic retinopathy, diabetic nephropathy
Baseline, 12 and 24 months
Quality measures of the T2DM care process
Time Frame: Baseline and 6, 12, 18 and 24 months
Adherence to recommendations on physical exam, lab test and treatment
Baseline and 6, 12, 18 and 24 months
Resource utilization and costs
Time Frame: Baseline and 3, 6, 12, 18 and 24 months
Baseline and 3, 6, 12, 18 and 24 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Pedro G Serrano-Aguilar, MD, PhD, Servicio de Evaluación del Servicio Canario de la Salud
  • Study Director: Pedro Serrano Aguilar, MD, PhD, Servicio de Evaluación del Servicio Canario de la Salud
  • Study Chair: Pedro Serrano Aguilar, MD, PhD, Servicio de Evaluación del Servicio Canario de la Salud

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2013

Primary Completion (Actual)

October 20, 2016

Study Completion (Actual)

October 20, 2016

Study Registration Dates

First Submitted

July 31, 2012

First Submitted That Met QC Criteria

August 3, 2012

First Posted (Estimate)

August 6, 2012

Study Record Updates

Last Update Posted (Actual)

October 4, 2021

Last Update Submitted That Met QC Criteria

September 27, 2021

Last Verified

September 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Type 2 Diabetes Mellitus

Clinical Trials on Intervention to patients

3
Subscribe